Refreshing results…
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
Download from www.nature.comRobust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
UploadPALB2 variant status in hematological malignancies – a potential therapeutic target?
UploadUnique features and clinical importance of acute alloreactive immune responses
Download from doi.orgMissing publications? Search for publications with a matching author name.